NCI Recognizes 11 Clinical Investigators with Leadership Awards || NCI Cancer Bulletin for November 1, 2011 - National Cancer Institute

 

NCI Recognizes 11 Clinical Investigators with Leadership Awards

NCI has announced the 2011 recipients of the Cancer Clinical Investigator Team Leadership Awards. These awards recognize 11 exceptional clinical investigators for their contributions to the advancement of clinical research through collaborative team science.

• Dr. Julie Bauman, University of New Mexico Cancer Center
• Dr. Tanios Bekaii-Saab, Ohio State University Comprehensive Cancer Center
• Dr. Anthony El-Khoueiry, University of Southern California Norris Comprehensive Cancer Center
• Dr. David Gerber, Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center
• Dr. Andrew Ko, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
• Dr. Antonio Omuro, Memorial Sloan-Kettering Cancer Center
• Dr. Chong-xian Pan, UC Davis Cancer Center, University of California, Davis
• Dr. John Sarantopoulos, Cancer Therapy & Research Center, UT Health Science Center at San Antonio
• Dr. Scott Schuetze, University of Michigan Comprehensive Cancer Center
• Dr. Tait Shanafelt, Mayo Clinic
• Dr. Brenda Weigel, Masonic Cancer Center, University of Minnesota

Designed for midlevel clinical investigators, these 2-year awards provide recognition and up to $50,000 in annual funding for those who lead cancer research programs and clinical trials at NCI-designated cancer centers. Recipients are expected to devote 10 to 15 percent of their time to the activities associated with this award.

This annual award, now in its third year, is the result of one of the recommendations of NCI's Clinical Trials Working Group. The Working Group was established to advise NCI on methods to improve and enhance the publicly funded cancer clinical trials enterprise.

"NCI is delighted to recognize these exceptional clinical investigators who serve as leaders for clinical research activities at their cancer centers," said Dr. Sheila Prindiville, director of NCI's Coordinating Center for Clinical Trials. "Dedicated clinical researchers like these individuals are crucial for advancing care for patients through clinical trials."

Learn more about how NCI is restructuring the national cancer clinical trials enterprise online.
NCI Cancer Bulletin for November 1, 2011 - National Cancer Institute